Atlas Trials

NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder

Clinical trial NCT00213577 · TERMINATED

Trial details

NCT number
NCT00213577
Sponsor
University Hospital, Rouen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Overactive Bladder
Start date
2003-12-01
Primary completion
2007-09-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.